Noble (NYSE:NE), Flotek (NYSE:FTK), American Water (NYSE:AWK): Backlog, EPA Approval and a Student Grant

Sonal Goyal

28 October 2026 12:12 AM AEDT

Noble (NYSE:NE), Flotek (NYSE:FTK), American Water (NYSE:AWK): Backlog, EPA Approval and a Student Grant

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Noble reported a Q3 net loss of $117 million and a $6.7 billion backlog.
Flotek's VeraCAL received EPA approval as ALT-163 for refinery flare monitoring.
American Water's foundation awarded a $10,000 grant to Junior Achievement of the Heartland.
Noble declared a $0.50 per share dividend for the fourth quarter.

Three companies with ties to energy and utilities issued announcements on October 26, 2026. Noble Corporation plc (NYSE:NE) reported third quarter results, Flotek Industries, Inc. (NYSE:FTK) announced an EPA approval for its VeraCAL system, and the American Water Charitable Foundation, established by American Water (NYSE:AWK), awarded a $10,000 grant.

Noble: Third Quarter Results

Noble reported revenue of $729 million, a net loss of $117 million ($0.73 per diluted share) and Adjusted EBITDA of $201 million. Free cash flow was negative $48 million, with total debt principal of $1.9 billion and cash of $337 million. Utilization of its 28 marketed rigs was 70%, versus 67% in the prior quarter. New contract awards since July total about $560 million, including a four-well TotalEnergies contract in Nigeria for Noble BlackRhino and a five-well Tullow contract in Ghana for Noble Faye Kozack, and backlog stands at $6.7 billion. The board approved a $0.50 per share dividend payable December 17, 2026. Full year revenue guidance was narrowed to $2,850 million to $2,900 million.

Flotek: VeraCAL Approval

The EPA approved VeraCAL as an alternative to gas chromatography for measuring flare vent gas composition and net heating value under 40 CFR Part 63, Subpart CC. Published as ALT-163, it is VeraCAL's second EPA alternative-method approval after July 2024. CEO Dr. Ryan Ezell called the approval an important step in expanding the Data Analytics business. Flotek said the system uses continuous optical measurement without carrier gas, and cited 130 operable U.S. refineries as of January 1, 2026. It noted that recent EPA rulemakings have extended similar monitoring requirements to certain chemical manufacturing and gasoline distribution operations.

American Water: Foundation Grant

The American Water Charitable Foundation and Iowa American Water announced a $10,000 Workforce Readiness grant to Junior Achievement of the Heartland for JA Finance Park, which teaches students budgeting, including household water, sewer and trash costs. The organization serves a 24 county region in Iowa and Illinois and sees more than 2,500 students aged 13 to 15 a year. The Foundation, led by president Carrie Williams, has invested over $25 million since 2012, is funded by American Water shareholders and has no impact on customer rates.

Why This Could Matter

Noble's backlog excludes mobilization and demobilization revenue. Noble described its awards as supporting fleet utilization through 2027, Flotek said the approval positions its Data Analytics business for refinery compliance monitoring, and the Foundation's grant falls under its Keep Communities Flowing Grant Program. American Water serves approximately 14 million people with regulated operations in 14 states.

Wrapping Up

The three announcements cover an offshore driller's quarterly figures and contract awards, a regulatory approval for a measurement system, and a community education grant, each as stated in the companies' releases.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.